brain-derived stem cell therapy (Celprogen/Indiana University School of Medicine)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Namebrain-derived stem cell therapy (Celprogen/Indiana University School of Medicine)

Drug Alias Namebrain-derived stem cell therapy (Celprogen)brain-derived stem cell therapy (Indiana University School of Medicine)

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Neurogenic potential stem cell therapy

Mechanisms of ActionNeuroprotectants

TargetsUpdating

Therapy Area/IndicationsNervous System Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCelprogen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCelprogen

Active IndicationsN/A

Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A